CompuGroup Medical Strengthens its Market Position in the Netherlands

CompuGroup MedicalCompuGroup Medical concluded an agreement to acquire 100% of the shares in Microbais Werkmaatschappij B.V.. Microbais is one of the market leaders in ambulatory and pharmacy information systems in the Netherlands. The 2011 turnover is expected to amount to 11.2 million Euro with about 70% recurring revenue and EBITDA is expected to be 2.5 million Euro.

Microbais employs around 90 employees and is headquartered in Amsterdam. Around 475 pharmacies as well as 150 doctors' practices count among the company's customers. This is equivalent to a market share of about 25% within pharmacies and 4% within office-based physicians.

With this acquisition CompuGroup Medical increases its market shares in the Dutch pharmacy and doctor software markets to around 45% and 15% respectively. Customers will be provided with access to the international product platform of CompuGroup Medical and benefit from SAM solutions (intelligent software assisted medicine) that are worldwide leading in terms of innovation and security.

In this transaction CompuGroup Medical also acquires a 51% majority holding in MediPharma Online, a start-up enterprise in the field of networking between patients and pharmacies.

Frank Gotthardt, CEO of CompuGroup Medical AG, underlined the relevance of this acquisition: "After the successful acquisition of Ascon Euroned, today CGM Netherlands, the purchase of Microbais is a crucial step towards extending the market position in the Dutch pharmacy software sector. At the same time we strengthen our coverage in the field of ambulatory information systems. The highly positive feedback from shareholders and employees of Microbais regarding this transaction encourages us in using this excellent start into the year 2012 with full power in the best interest of our customers."

The purchase price amounts to approximately 15,0 million Euro and will be financed from existing cash and credit facilities.

Related news articles:

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 385,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 33 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 3,600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...